My UM
My UM
Search

Mickaël Hiligsmann (M.J.C.)

Recent publications
  • Li, N., Majoie, M., Evers, S., Rijkers, K., Gubler, F., Rouhl, R., Lazeron, R., Klarenbeek, P., Laskier-Owens, V., & Hiligsmann, M. (2025). Budget impact analysis of cenobamate for epilepsy patients with drug-resistant focal onset seizures in the Netherlands. Journal of Medical Economics, 28(1), 114-123. https://doi.org/10.1080/13696998.2024.2443338
    More information about this publication
  • Schoonvelde, S. A. C., Wiethoff, I., Zwetsloot, P. P., Hirsch, A., Knackstedt, C., Germans, T., Sikking, M., Schinkel, A. F. L., van Slegtenhorst, M. A., Verhagen, J. M. A., de Boer, R. A., Evers, S. M. A. A., Hiligsmann, M., & Michels, M. (2025). Loss of quality of life and increased societal costs in patients with hypertrophic cardiomyopathy: the AFFECT-HCM study. European heart journal - Quality of care & clinical outcomes, 11(2), 174-185. https://doi.org/10.1093/ehjqcco/qcae092
    More information about this publication
  • Maas, L., Peeters, C. B. C. M., Hiligsmann, M., vanKuijk, S. M. J., Tousseyn, S., Kellenaers, J., vanMastrigt, G. A. P. G., Vlooswijk, M. C. G., Klinkenberg, S., Wagner, L., Nelissen, J., Schijns, O. E. M. G., Majoie, H. J. M., Rijkers, K., ACE Epilepsy Surgery Group, Dings, J., Hilkman, D., van der Pol, J., van Kranen - Mastenbroek, V., ... van Straaten, I. (2025). A prospective cohort study estimating total pre-surgical healthcare costs before and two-year total societal costs after resective brain surgery, and quality of life of patients with drug-resistant epilepsy undergoing surgery. Journal of Medical Economics, 28(1), 364-376. https://doi.org/10.1080/13696998.2025.2473745
    More information about this publication
  • Ecarnot, F., Thiyagarajan, J. A., Barbagallo, M., Barratt, J., Constantinescu, S., Elkayam, O., Ferrucci, L., Hiligsmann, M., Kapetanovic, M., Macchia, F., Michel, J.-P., Migliore, A., Pilotto, A., Sieber, C., Strangfeld, A., Veronese, N., Vetrano, D. L., Maggi, S., & Rizzoli, R. (2025). Musculoskeletal diseases, infections and vaccines: state of the art, research perspectives and educational needs. Aging Clinical and Experimental Research, 37(1), Article 46. https://doi.org/10.1007/s40520-025-02940-w
    More information about this publication
  • Fuggle, N., Laslop, A., Rizzoli, R., Al-Daghri, N., Alokail, M., Balkowiec-Iskra, E., Beaudart, C., Bruyere, O., Botto-van Bemden, A., Burlet, N., Cavalier, E., Cerreta, F., Chandran, M., Cherubini, A., da Silva Rosa, M. M. C., Conaghan, P., Cortet, B., Jentoft, A. C., Curtis, E. M., ... Harvey, N. C. (2025). Treatment of Osteoporosis and Osteoarthritis in the Oldest Old. Drugs, 343-360. Article e031734. https://doi.org/10.1007/s40265-024-02138-w
    More information about this publication
  • Nagendra, L., Chandran, M., Reginster, J.-Y., Bhadada, S. K., Bhattacharya, S., Dutta, D., & Hiligsmann, M. (2025). Cost-effectiveness of FRAX<SUP>®</SUP>-based intervention thresholds for management of osteoporosis in Indian women: a Markov microsimulation model analysis. Osteoporosis International, 36(2), 311-322. https://doi.org/10.1007/s00198-024-07328-6
    More information about this publication
  • Saadat, P., Bansback, N., Falahee, M., Hiligsmann, M., Tugwell, P., Buchbinder, R., Whittle, S., Richards, D. P., Proulx, L., Schunemann, H., Alonso-Coello, P., Nieuwlaat, R., Wiercioch, W., Kuper, S., Pardo Pardo, J., & Hazlewood, G. (2025). Patient preferences for drug therapy in inflammatory arthritis: protocol for a living systematic review and evidence map to inform clinical practice guidelines. BMJ Open, 15(1), Article e088267. https://doi.org/10.1136/bmjopen-2024-088267
    More information about this publication
  • Sharma, M., Beaudart, C., Clark, P., Fujiwara, S., Adachi, J. D., Papaioannou, A., Messina, O. D., Morin, S. N., Kohlmeier, L., Nogues, X., Leckie, C., Harvey, N. C., Kanis, J. A., Reginster, J.-Y., Hiligsmann, M., & Silverman, S. L. (2025). Clinical and demographic factors determining patient fracture risk decision point (FRDP): The improving risk communication in osteoporosis (RICO) project. Osteoporosis International, 36(1), 71-80. https://doi.org/10.1007/s00198-024-07264-5
    More information about this publication
  • van der Meer, F., Jorgensen, J., & Hiligsmann, M. (2025). Burden of non-motor symptoms of Parkinson's disease: cost-of-illness and quality-of-life estimates through a scoping review. Expert Review of Pharmacoeconomics & Outcomes Research, 25(1), 17-27. https://doi.org/10.1080/14737167.2024.2390042
    More information about this publication
  • Abraham, I., Hiligsmann, M., Lee, K. K. C., Citrome, L., Colombo, G. L., & Gregg, M. (2024). What to expect in 2024: important health economics and outcomes research (HEOR) trends. Journal of Medical Economics, 27(1), 69-76. https://doi.org/10.1080/13696998.2023.2291604
    More information about this publication
Go to all publications